Pricing Log in Create free account

AC Immune (ACIU) vs Rocket Pharmaceuticals, Inc. (RCKT)

AC Immune and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. AC Immune and Rocket Pharmaceuticals, Inc. are of similar size ($259.1M and $249.4M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1,783.7%) and the lower return on invested capital (−114.7% vs 0.00%). Across the 13 metrics below, Rocket Pharmaceuticals, Inc. leads on 7 and AC Immune on 6.

Valuation

Metric ACIU RCKT Biotechnology median
P/E n/m n/m 8.50
P/S 50.83 n/m 9.71
P/B 5.30 0.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.07 0.64
EV/Sales 31.31 n/m 9.21
Earnings yield (34.31%) (7.34%) (33.15%)
Free cash flow yield (35.48%) (69.93%) (25.50%)

Profitability

Metric ACIU RCKT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,745.75%) 0.00% 0.00%
Net margin (1,783.66%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (4.77%) (56.36%)
Return on assets 0.00% (4.09%) (48.04%)
Return on invested capital 0.00% (114.71%) 0.00%

Growth

Metric ACIU RCKT Biotechnology median
Revenue growth (TTM) (85.56%) — 6.02%
EPS growth (last fiscal year) (44.83%) 26.37% 30.26%
Revenue growth, 5-year CAGR (47.84%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACIU RCKT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 0.93 9.24 4.72
Net debt to EBITDA 1.37 0.77 0.96

Dividend

Metric ACIU RCKT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACIU RCKT Biotechnology median
Market cap 249.35m 259.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack